The MBS Review Taskforce has released a large number of proposed changes to oncology items in areas such as chemotherapy management, tumour markers and diagnostic imaging. Its reports, released a few days before Christmas, contain recommendations from numerous Taskforce’s clinical committees including medical oncology, pathology and nuclear medicine. Significant changes include an overhaul of existing items ...
Widespread changes to oncology items proposed by MBS Review Taskforce
By Michael Woodhead
14 Jan 2019